Preprints—studies released online before peer review—need extra caution in health news because they haven’t passed the rigorous scrutiny that peer review provides. Without independent experts examining the data and methods, misleading health claims can reach media outlets and the public, only to be contradicted or withdrawn months or years later. This is especially risky for readers seeking reliable information about brain health, dementia care, or aging. The problem is not that preprints should never exist.
Scientists use preprint servers to share research quickly and get early feedback. But when journalists and health communicators treat preprints as if they’re the same as published, vetted research, patients and caregivers may make health decisions based on findings that were later disproven or retracted. During the COVID-19 pandemic, for example, a widely circulated preprint falsely claimed to find similarities between the coronavirus and HIV—a claim that spread rapidly through social media and news before being debunked. This is why distinguishing preprints from peer-reviewed work has become critical to responsible health communication.
Table of Contents
- What Happens When Health Research Skips Peer Review?
- How Many Preprints Never Get Published in a Real Journal?
- Why Media Coverage of Preprints Spreads Unverified Health Claims
- How to Evaluate a Preprint Before Believing It
- Scientific Misconduct and Retractions: Hidden Dangers in Unreviewed Research
- COVID-19 Revealed Both the Benefits and Dangers of Rapid Preprint Publishing
- The Peer Review System Isn’t Perfect, But It Remains Essential for Health Claims
What Happens When Health Research Skips Peer Review?
peer review exists as a gatekeeper. Before a study appears in a medical journal, independent experts in the field examine the methods, data, and conclusions to identify flaws, biases, or unsupported leaps. This process is imperfect, but it catches many errors and catches them before the research shapes public health decisions. Preprints bypass this step entirely.
A researcher can post findings to a server like medRxiv or bioRxiv without anyone else having verified the work first. The consequence is that problematic research can circulate for months or years unchallenged. When a preprint lacks peer review, methodological flaws go unquestioned, overstated conclusions reach readers uncritically, and conflicts of interest may not be disclosed or scrutinized. For a disease like dementia, where families are desperate for hope and new treatments, an unvetted preprint claiming a breakthrough can spread quickly and influence patient expectations before the medical community has had a chance to evaluate its validity. There is no built-in correction mechanism until—and only if—the preprint is eventually submitted to a journal, reviewed, and found wanting.
How Many Preprints Never Get Published in a Real Journal?
One striking fact reveals the scale of the problem: approximately 55% of preprints are never published in a peer-reviewed journal. This means that more than half of all research released to the public online never undergoes the scrutiny of formal peer review. Those unvalidated claims remain in circulation indefinitely, cited in news articles, social media discussions, and patient forums as if they were established science. When a preprint fails to appear in a journal, it’s often because reviewers identified serious flaws or misconduct.
But by the time a preprint is rejected, it has already been downloaded, quoted in media stories, and absorbed into the public conversation. The damage is done. For health topics, this creates a disturbing asymmetry: studies that pass peer review get published and cited as reliable; studies that fail peer review often disappear from academic databases but linger in Google search results, news archives, and the memory of people who read about them. A dementia caregiver who reads a preprint claiming a new cognitive intervention works may invest hope and resources based on that claim, unaware that the study never survived scrutiny from experts.
Why Media Coverage of Preprints Spreads Unverified Health Claims
Journalists face pressure to report on health research quickly. Preprints allow reporters to cover emerging findings before peer review is complete, especially when the story seems important or timely. But research shows that journalists frequently promote preprints without clearly distinguishing them from peer-reviewed articles. News headlines and social media posts often omit the word “preprint” entirely, presenting preliminary findings with the same authority as established science. The result is that unvalidated health claims are repeated in news media “in undifferentiated or uncritical ways,” according to studies analyzing media coverage.
During the COVID-19 pandemic, this problem accelerated dramatically. Journalists relied heavily on preprints to cover urgent developments in the pandemic, and media outlets reported on preliminary virus research, vaccine studies, and treatment proposals without always flagging that the work hadn’t been peer-reviewed. one high-profile example was the preprint claiming coronavirus shared structural similarities with HIV—a claim that generated headlines and social media alarm before being discredited by other researchers. The media’s role in amplifying preprints was so pronounced that public health agencies and medical journals eventually issued guidance urging caution. Importantly, analysis of media coverage from 2014 to 2023 revealed a significant post-pandemic decline in journalist reliance on preprints, suggesting that the field learned lessons from those experiences.
How to Evaluate a Preprint Before Believing It
When you encounter a health story or study online, especially one about brain health or dementia, ask three practical questions. First, does the story use the word “preprint” explicitly, or does it acknowledge that the research hasn’t been peer-reviewed? If the source downplays or omits this fact, treat the claim as preliminary. Second, who funded the research, and does the study have any obvious conflicts of interest? Preprints often lack the disclosure requirements that journals enforce. Third, what do established medical organizations say about the topic? If a major health authority hasn’t mentioned a breakthrough that a preprint claims to have found, there’s a reason—experts have likely not yet validated it. Compare this to peer-reviewed research: when a major medical journal publishes a study on dementia risk or treatment, the journal’s website clearly identifies it as published and peer-reviewed.
The study has been vetted by experts. If it’s groundbreaking, it will be discussed at medical conferences and assessed by guideline committees. Preprints don’t have these markers of validation. A preprint may eventually become a published, peer-reviewed study—in which case, wait for the peer-reviewed version before acting on its findings. If you read a health claim about dementia or brain health that sounds dramatic but you can’t find it confirmed by established medical sources or journals, it’s likely still in preprint form and not yet validated.
Scientific Misconduct and Retractions: Hidden Dangers in Unreviewed Research
Preprints are vulnerable to a particular risk that peer review is designed to catch: scientific misconduct. As of April 2026, scientific misconduct—falsification, fabrication, and plagiarism—accounts for 60% of all research retractions. When a preprint is published without peer review, fabricated data or plagiarized text can go undetected. Even worse, a growing number of retracted studies come from “paper mills,” operations that generate fraudulent research for profit. Between 2016 and 2025, one-fifth of all retracted health science and basic life science articles originated from paper mills.
The irony is grim: preprint servers like Research Square, bioRxiv, and medRxiv have retracted very few preprints (only 0.01% have been retracted). That sounds reassuring, but it actually indicates that misconduct often goes undetected and uncorrected on preprint servers. Of the 30 retractions identified across major preprint platforms, only 11 were clearly noted by the servers themselves, and only 1 retraction was acknowledged by the journal that eventually rejected the preprint. This poor communication means that someone reading the original preprint months later may have no way to know it was fraudulent. For a caregiver researching dementia treatments online, a paper mill study promoting a dubious supplement might appear in search results indefinitely, never flagged as retracted or unreliable.
COVID-19 Revealed Both the Benefits and Dangers of Rapid Preprint Publishing
The COVID-19 pandemic exposed how preprints can be both invaluable and risky. In early 2020, when there was urgent need for rapid information sharing, preprint servers became essential. Scientists worldwide could release findings about virus transmission, vaccine development, and treatment options without waiting for the months-long peer review process. This speed was medically and socially important. But the same urgency bred carelessness. Journalists covered preprints without their usual skepticism.
Readers treated preliminary findings as established fact. Social media amplified sensational claims before they could be checked. The post-pandemic period has brought a correction. Analysis of media coverage shows that journalists have significantly reduced their reliance on preprints since 2023. News organizations have become more careful to label preprints explicitly and to wait for peer review before treating findings as definitive. This shift suggests that the health and science journalism community learned that rapid reporting without peer review protection carries real costs. For readers trying to stay informed about health topics today, this postpandemic caution is a positive sign—though vigilance remains necessary.
The Peer Review System Isn’t Perfect, But It Remains Essential for Health Claims
Acknowledging that preprints need caution doesn’t mean peer review guarantees truth. Peer review is slow, sometimes biased, and occasionally misses errors or misconduct. Published studies are retracted, and peer-reviewed journals have published research that later failed to replicate. But these failures occur within a system where oversight and correction are possible. A published study is indexed in databases, tracked by medical authorities, and subject to scrutiny by thousands of researchers in the field.
If it’s wrong or fraudulent, others can and do identify the problem and publish corrections or retractions. A preprint exists outside this system. It has no permanence, no active community of reviewers monitoring it, and no institutional responsibility for accuracy. When a peer-reviewed study fails, the failure is documented and visible. When a preprint is wrong, it may simply remain online as a source of misinformation, cited in blog posts, health forums, and social media by people unaware it was never validated.
- —
